一种微型半导体像素探测器Timepix3被用于评估调强质子治疗(IMPT)方案中的辐射质量，尤其关注线性能量转移(LET)。该研究由波兰科学院核物理研究所的研究人员进行，在均匀和异质体模中进行了实验验证。实验结果表明，Timepix3探测器能够有效验证IMPT方案中的LET计算，并进行患者特定质量保证。该技术有望在临床环境中得到应用，从而提高质子治疗的有效性。

🔬Timepix3探测器：该研究使用Timepix3作为微型在线辐射相机，通过降低束流强度，克服了临床束流中探测器饱和的问题。Timepix3能够提供准连续的单粒子追踪，从而识别粒子类型和光谱信息。

🧪实验验证：研究人员在Cyclotron Centre Bronowice (CCB)的治疗室中进行了一系列实验，使用均匀水等效体模和异质头部体模，分别测量了扩展布拉格峰(SOBP)和IMPT方案的能量沉积和LET谱，并将测量结果与蒙特卡罗(MC)模拟结果进行比较。

🎯临床转化：研究人员指出，将Timepix3应用于临床需要升级束流输送系统，以实现在低束流强度下的束流监测。目前商业临床或质保模式尚不支持pA级束流扫描。

📈LET的意义：通过将LET纳入优化参数，可以更好地利用质子的放射生物学特性，降低健康组织的LET，同时维持或增加靶区内的LET，从而优化临床治疗计划。

🤝未来展望：研究人员认为，Timepix3探测器具有结构紧凑和商业可得的优势，有望在质子治疗中心得到广泛应用，从而支持LET在治疗计划中的实施，最终提高治疗效果。

Proton therapy is a highly effective and conformal cancer treatment. Proton beams deposit most of their energy at a specific depth – the Bragg peak – and then stop, enabling proton treatments to destroy tumour cells while sparing surrounding normal tissue. To further optimize the clinical treatment planning process, there’s recently been increased interest in considering the radiation quality, quantified by the proton linear energy transfer (LET).

LET – defined as the mean energy deposited by a charged particle over a given distance – increases towards the end of the proton range. Incorporating LET as an optimization parameter could better exploit the radiobiological properties of protons, by reducing LET in healthy tissue, while maintaining or increasing it within the target volume. This approach, however, requires a method for experimental verification of proton LET distributions and patient-specific quality assurance in terms of proton LET.

To meet this need, researchers at the Institute of Nuclear Physics, Polish Academy of Sciences have used the miniaturized semiconductor pixel detector Timepix3 to perform LET characterization of intensity-modulated proton therapy (IMPT) plans in homogeneous and heterogeneous phantoms. They report their findings in Physics in Medicine & Biology.

Experimental validation

First author Paulina Stasica-Dudek and colleagues performed a series of experiments in a gantry treatment room at the Cyclotron Centre Bronowice (CCB), a proton therapy facility equipped with a proton cyclotron accelerator and pencil-beam scanning system that provides IMPT for up to 50 cancer patients per day.

The MiniPIX Timepix3 is a radiation imaging pixel detector based on the Timepix3 chip developed at CERN within the Medipix collaboration (provided commercially by Advacam). It provides quasi-continuous single particle tracking, allowing particle type recognition and spectral information in a wide range of radiation environments.

For this study, the team used a Timepix3 detector with a 300 µm-thick silicon sensor operated as a miniaturized online radiation camera. To overcome the problem of detector saturation in the relatively high clinical beam currents, the team developed a pencil-beam scanning method with the beam current reduced to the picoampere (pA) level.

The researchers used Timepix3 to measure the deposited energy and LET spectra for spread-out Bragg peak (SOBP) and IMPT plans delivered to a homogeneous water-equivalent slab phantom, with each plan energy layer irradiated and measured separately. They also performed measurements on an IMPT plan delivered to a heterogeneous head phantom. For each scenario, they used a Monte Carlo (MC) code to simulate the corresponding spectra of deposited energy and LET for comparison.

The team first performed a series of experiments using a homogeneous phantom irradiated with various fields, mimicking patient-specific quality assurance procedures. The measured and simulated dose-averaged LET (LET_d) and LET spectra agreed to within a few percent, demonstrating proper calibration of the measurement methodology.

The researchers also performed an end-to-end test in a heterogeneous CIRS head phantom, delivering a single field of an IMPT plan to a central 4 cm-diameter target volume in 13 energy layers (96.57–140.31 MeV) and 315 spots.

For head phantom measurements, the peak positions for deposited energy and LET spectra obtained based on experiment and simulation agreed within the error bars, with LET_d values of about 1.47 and 1.46 keV/µm, respectively. The mean LET_d values derived from MC simulation and measurement differed on average by 5.1% for individual energy layers.

Clinical translation

The researchers report that implementing the proposed LET measurement scheme using Timepix3 in a clinical setting requires irradiating IMPT plans with a reduced beam current (at the pA level). While they successfully conducted LET measurements at low beam currents in the accelerator’s research mode, pencil-beam scanning at pA-level currents is not currently available in the commercial clinical or quality assurance modes. Therefore, they note that translating the proposed approach into clinical practice would require vendors to upgrade the beam delivery system to enable beam monitoring at low beam currents.

“The presented results demonstrate the feasibility of the Timepix3 detector to validate LET computations in IMPT fields and perform patient-specific quality assurance in terms of LET. This will support the implementation of LET in treatment planning, which will ultimately increase the effectiveness of the treatment,” Stasica-Dudek and colleagues write. “Given the compact design and commercial availability of the Timepix3 detector, it holds promise for broad application across proton therapy centres.”

The post Miniaturized pixel detector characterizes radiation quality in clinical proton fields appeared first on Physics World.